Advances in the Therapeutic Management of Patients with Chronic Hematological Conditions – A Whiteboard Preceptorship

Med Learning Group has designed this innovative, multi-format educational program aimed at increasing HCP’s ability to: incorporate the latest clinical data into the treatment of patients with hemophilia and sickle cell disease, individualize management based on patient-specific factors, and incorporate a shared decision making and a multidisciplinary approach to patient care.

Friday, December 10, 2021
11:00 AM – 11:30 AM Registration and Breakfast
11:30 AM – 1:00 PM Symposium

Georgia World Congress Center
285 Andrew Young International Blvd NW
Atlanta, Georgia
Meeting Room: Thomas Murphy 1-2

Program Features

• Quality Improvement Personalized Posters: To proactively support more patient-centric care, an online poster portal will be available for all learners, where you can select images to create your own personalized practice poster, which will then be sent to you so that it can be hung in your practice setting. In addition to the physically printed posters, learners will also receive a PDF version via email to use during telehealth sessions. These posters will serve as an effective reminder of the education and the clinical pearls that were reviewed by the faculty. The images for these posters will be specifically designed to promote dialogue around evidence from clinical trials assessing available and emerging therapies for the treatment of patients with chronic hematologic conditions including hemophilia and SCD and evaluating patient-specific characteristics when developing individualized management plans.
• Whiteboard Animations – During the live activity, there will be an innovative learning experience incorporating whiteboard animations to supplement the didactic learning, to help learners better visualize the pathophysiology of hemophilia and sickle cell disease, as well as the mechanism of action of emerging therapies for the treatment of patients with hemophilia and SCD. At the conclusion of the ASH Symposium, learners will have access to downloadable whiteboard animations to view and share post-education. These animations have proven useful in engaging patients and caregivers in care and sharing education with participants’ colleagues.

Faculty

Michael White, MD, MSC
Pediatric Hematology/Oncology,
Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Assistant Professor of Pediatrics,
Emory University School of Medicine
Atlanta, GA

Martin H. Steinberg, MD
Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine
Division of Hematology/Oncology
Boston University School of Medicine
Boston, MA

AGENDA

1. Hemophilia: An Overview
   1. Epidemiology
   2. Pathophysiology
   3. Clinical, social, and economic burdens
2. Challenges in Diagnosis and Management of Patients with Hemophilia
   1. Screening and diagnostic methods
   2. Acute care management of patients with hemophilia and SCD in emergency care settings and the important role of emergency medicine physicians
   3. Personalizing treatment
3. Review of MOAs and Clinical Trial-derived Efficacy and Safety Data in Hemophilia
   1. Standard of care therapies and associated unmet needs
   2. Approved agents
   3. Emerging agents
4. Sickle Cell Disease: An Overview
   1. Epidemiology
   2. Pathophysiology
   3. Clinical, social, and economic burdens
5. Challenges in Diagnosis and Management of Patients with Sickle Cell Disease
   1. Screening and diagnostic methods
   2. Acute care management of patients with hemophilia and SCD in emergency care settings and the important role of emergency medicine physicians
   3. Personalizing treatment
6. Review of MOAs and Clinical Trial-derived Efficacy and Safety Data in Sickle Cell Disease
   1. Standard of care therapies and associated unmet needs
   2. Approved agents
   3. Emerging agents
7. Multidisciplinary Team-based Patient-Centered Shared Decision Making (SDM) Approaches to the Management of Chronic Hematological Conditions
   1. Benefits of multidisciplinary team-based approaches to the management of patients with chronic hematological conditions
   2. Team members and their respective roles
   3. Benefits of SDM approaches in general
   4. SDM approaches specific to patients with chronic hematological conditions
8. Case Studies

Learning Objectives

After completing the CME activity, learners should be better able to:

• Evaluate evidence from clinical trials assessing available and emerging therapies for the treatment of patients with chronic hematologic conditions including hemophilia and SCD
• Evaluate patient-specific characteristics when developing individualized management plans for those with chronic hematologic conditions including hemophilia and SCD
• Facilitate a multidisciplinary patient-centered SDM approach to the management of those with chronic hematologic conditions including hemophilia and SCD

Target Audience

This activity is designed to meet the educational needs of hematologists, emergency medicine physicians, and other healthcare practitioners who treat patients with hemophilia A or B and SCD.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of  1.50 AMA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with chronic hematologic conditions including hemophilia and SCD.

CNE Credits: 1.5 ANCC Contact Hour

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.5 contact hours of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. 

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.